الفهرس 
Staging of breast cancerOnly 14 pages are availabe for public view
 |  | from | 249 |  |  |
| | | from | 249 | | |
Abstract
This work is a comparative, prospective, randomized study to assess the use of taxanes-anthracycline based regimen {TAC(or)AT} versus the standard anthracycline based regimen (FAC) as NACT in locally advanced breast cancer and as frist line chemotherapy in MBC patients;